Head and neck manifestations of the immune reconstitution syndrome in HIV-infected patients: A cohort study

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 1, 2012, Pages 52-56

  Ablanedo Terrazas, Yuria ^a   Alvarado De La Barrera, Claudia ^a   Ormsby, Christopher E ^a   Reyes Terán, Gustavo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

facial palsy; head and neck Kaposi sarcoma; HIV; immune reconstitution inflammatory syndrome; lymph node histoplasmosis; lymph node tuberculosis

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BIOPSY; BLOOD CHEMISTRY; BODY FLUID; COHORT ANALYSIS; CONTROLLED STUDY; ENT EXAMINATION; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HEMATOLOGY; HERPES SIMPLEX; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; LYMPH NODE HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MEXICO; MYCOBACTERIUM INTRACELLULARE AVIUM; PROSPECTIVE STUDY; RETROPHARYNGEAL ABSCESS; SCROPHULARIACEAE; TERTIARY HEALTH CARE; TUBERCULOSIS; VOCAL CORD PARALYSIS; EAR NOSE THROAT DISEASE; HEAD AND NECK TUMOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

ADULT; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; OTORHINOLARYNGOLOGIC DISEASES; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; TUBERCULOSIS;

EID: 84866040183     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812437321     Document Type: Article

References (20)

1. Shelburne S, Montes M, Hamill R. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicr Chem. 2006 ; 57: 167-170 (Pubitemid 43160154)
2. Shelburne S, Hamill R, Rodriguez-Barradas M, et al. Immune reconstitution inflammatory syndrome. Medicine. 2002 ; 81: 213-227
3. Shelburne S, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 ; 19: 399-406 (Pubitemid 40446186)
4. Ratnam C, Kandala C, Easterbrook J. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006 ; 42: 418-427
5. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr. 2007 ; 46: 456-462 (Pubitemid 350098697)
6. Puthanakit T, Oberdorfer P, Akarathum N, et al. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatr Infect Dis J. 2006 ; 25: 53-58 (Pubitemid 43361477)
7. Dhasmana D, Dheda K, Ravn P, Wilkinson RJ, Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy. Drugs. 2008 ; 68: 191-208
8. Bonham S, Meya DB, Bohjanen PR, Boulware DR. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med. 2008 ; 2: 349-361
9. Espinosa E, Peña-Jiménez Á, Ormsby CE, Vega-Barrientos R, Reyes-Terán G. Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome. HIV Med. 2009 ; 10: 454-457
10. Müller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010 ; 10: 251-261
11. Jaffe H, De Stavola B, Carpenter L, Porter K, Cox D. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS. 2011 ; 25: 1395-1403
12. Chan-Tack KM, Chengappa KS, Wolf JS, Kao GF, Reisler RB. Immune reconstitution inflammatory syndrome presenting as sinusitis with inflammatory pseudotumor in an HIV-infected patient: a case report and review of the literature. AIDS Patient Care STDs. 2006 ; 20: 823-828 (Pubitemid 46106069)
13. Leidner R, Aboulafia D. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDs. 2005 ; 19: 635-644 (Pubitemid 41527674)
14. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January10, 2011;1-166. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed August 29, 2011.
15. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008 ; 8: 516-523 (Pubitemid 352005824)
16. Manosuthi W. Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2009 ; 23: 2467-2471
17. Phillips P, Bonner S, Nada G, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis. 2005 ; 4115: 1483-1497 (Pubitemid 41579994)
18. World Health Organization. Global tuberculosis control2011. http://who.int/mapLibrary/app/searchResults.aspx.
19. Murdoch DM, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008 ; 22: 601-610 (Pubitemid 351640593)
20. Grant PM, Komarow L, Andersen J, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE. 2010 ; 5 (7). e11416